These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2075 related articles for article (PubMed ID: 7074591)

  • 21. Melastatin expression and prognosis in cutaneous malignant melanoma.
    Duncan LM; Deeds J; Cronin FE; Donovan M; Sober AJ; Kauffman M; McCarthy JJ
    J Clin Oncol; 2001 Jan; 19(2):568-76. PubMed ID: 11208852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cutaneous malignant melanoma in the area of the head and neck with intermediate tumor thickness: does primary site have prognostic relevance?].
    Wenzel S; Metternich FU; Sagowski C; Neuber K; Kehrl W
    Laryngorhinootologie; 2001 Jun; 80(6):313-7. PubMed ID: 11475610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic significance of ulceration of cutaneous melanoma.
    Balch CM; Wilkerson JA; Murad TM; Soong SJ; Ingalls AL; Maddox WA
    Cancer; 1980 Jun; 45(12):3012-7. PubMed ID: 7388745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment Outcome and Prognostic Factors for Malignant Skin Melanoma Treated with Radical Surgery.
    Majewski W; Stanienda K; Wicherska K; Ulczok R; Wydmanski J
    Asian Pac J Cancer Prev; 2015; 16(14):5709-14. PubMed ID: 26320440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor thickness and prognosis in clinical stage I malignant melanoma.
    Karakousis CP; Emrich LJ; Rao U
    Cancer; 1989 Oct; 64(7):1432-6. PubMed ID: 2776106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional non-nodal metastases of cutaneous melanoma.
    Cascinelli N; Bufalino R; Marolda R; Belli F; Nava M; Galluzzo D; Santinami M; Levene A
    Eur J Surg Oncol; 1986 Jun; 12(2):175-80. PubMed ID: 3709823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis in patients with thin malignant melanoma: influence of regression.
    McGovern VJ; Shaw HM; Milton GW
    Histopathology; 1983 Sep; 7(5):673-80. PubMed ID: 6629343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage II malignant melanoma: presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patients.
    Slingluff CL; Vollmer R; Seigler HF
    J Surg Oncol; 1988 Nov; 39(3):139-47. PubMed ID: 3184950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local and in-transit metastases following definitive excision for primary cutaneous malignant melanoma.
    Roses DF; Harris MN; Rigel D; Carrey Z; Friedman R; Kopf AW
    Ann Surg; 1983 Jul; 198(1):65-9. PubMed ID: 6859994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma.
    Balch CM; Soong SJ; Murad TM; Ingalls AL; Maddox WA
    Surgery; 1979 Aug; 86(2):343-51. PubMed ID: 462379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
    Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socioeconomic status.
    MacKie RM; Hole DJ
    BMJ; 1996 May; 312(7039):1125-8. PubMed ID: 8620127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous melanomas that defy conventional prognostic indicators.
    McCarthy WH; Shaw HM; McCarthy SW; Rivers JK; Thompson JF
    Semin Oncol; 1996 Dec; 23(6):709-13. PubMed ID: 8970591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors in thin cutaneous malignant melanoma.
    Salman SM; Rogers GS
    J Dermatol Surg Oncol; 1990 May; 16(5):413-8. PubMed ID: 2187914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors in head and neck melanoma. Effect of lesion location.
    Wanebo HJ; Cooper PH; Young DV; Harpole DH; Kaiser DL
    Cancer; 1988 Aug; 62(4):831-7. PubMed ID: 3395962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant melanoma in the elderly.
    Cohen HJ; Cox E; Manton K; Woodbury M
    J Clin Oncol; 1987 Jan; 5(1):100-6. PubMed ID: 3806154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological behavior and natural course of acral malignant melanoma. Clinical and histologic features and prognosis of palmoplantar, subungual, and other acral malignant melanomas.
    Jimbow K; Takahashi H; Miura S; Ikeda S; Kukita A
    Am J Dermatopathol; 1984; 6 Suppl():43-53. PubMed ID: 6528942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival among patients with clinical stage I cutaneous malignant melanoma diagnosed in Western Australia in 1975/1976 and 1980/1981.
    Heenan PJ; English DR; Holman CD; Armstrong BK
    Cancer; 1991 Nov; 68(9):2079-87. PubMed ID: 1913557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognosis of patients with stage III melanoma. Prospective long-term study of 286 patients of the Fachklinik Hornheide.
    Drepper H; Biess B; Hofherr B; Hundeiker M; Lippold A; Otto F; Padberg G; Peters A; Wiebelt H
    Cancer; 1993 Feb; 71(4):1239-46. PubMed ID: 8435800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 104.